McKesson Ventures

McKesson Ventures is the corporate venture capital arm of McKesson, a global healthcare company. The firm focuses on investing in venture and growth-stage companies that develop innovative software and services for the healthcare and pharmaceutical industries. Their investment strategy is centered on supporting entrepreneurs and seasoned teams who are building businesses that address significant challenges within the healthcare ecosystem, aiming to create a more efficient and effective healthcare delivery system. They leverage McKesson's extensive industry expertise and connections to help their portfolio companies scale and succeed.

Founded in 2014 by Tom Rodgers, who also served as its initial leader before transitioning to his role as EVP and Chief Strategy Officer for McKesson, the firm was established to strategically invest in the evolving healthcare landscape. McKesson Ventures seeks to identify and back companies that both catalyze and benefit from key changes in the healthcare ecosystem, focusing on long-term strategic needs rather than tactical business unit requirements. This approach allows them to act as a true investment partner, offering unique insights into areas like pharma and oncology, along with introductions to industry experts.

The firm's diverse portfolio includes notable investments in companies such as Komodo Health, which tracks patient journeys; Aledade, focused on value-based care for primary care; Clinical Ink, bringing data and technology to clinical research; Midi Health, addressing women's midlife health; and IVX Health, redefining infusion experiences. Recent investments also include Prudentia Sciences in biotechnology research, Latent in clinical AI, and Oath Surgical for AI-native surgical centers. These investments span various stages, from Series A to Growth, demonstrating their commitment to supporting companies throughout their development.

The McKesson Ventures team comprises individuals with deep healthcare experience as both investors and operators. Key team members include Dave Schulte, President, and partners like Jennifer Carter and Michelle Snyder, who bring extensive backgrounds in venture operations, marketing, and strategic planning within the healthcare sector. The team's collective expertise in healthcare technology, life sciences, and digital health, combined with their alignment with entrepreneurial interests, positions them as engaged and committed partners to their portfolio companies.